EFFECT OF SULPIRIDE ON MONOAMINERGIC MECHANISMS IN PSYCHOTIC WOMENBJERKENSTEDT L; HARNRYD C; SEDVAL G et al.1979; PSYCHOPHARMACOLOGY; DEU; DA. 1979; VOL. 64; NO 2; PP. 135-139; BIBL. 33 REF.Article

EFFECTS OF MELPERONE AND THIOTHIXENE ON PROLACTIN LEVELS IN CEREBROSPINAL FLUID AND PLASMA OF PSYCHOTIC WOMEN.BJERKENSTEDT L; ENEROTH P; HARNRYD C et al.1977; ARCH. PSYCHIATR. NERVENKRANKH.; DTSCH.; DA. 1977; VOL. 224; NO 4; PP. 281-293; BIBL. 1 P. 1/2Article

RELATIONSHIPS BETWEEN CLINICAL AND BIOCHEMICAL EFFECTS OF MELPERONE AND THIOTHIXENE IN PSYCHOTIC WOMENBJERKENSTEDT L; GULLBERG B; HAERNRYD C et al.1979; ARCH. PSYCHIATR. NERVENKRANKH.; DEU; DA. 1979; VOL. 227; NO 3; PP. 181-192; ABS. GER; BIBL. 2 P.Article

REDUCTION OF MOPEG LEVELS IN CEREBROSPINAL FLUID OF PSYCHOTIC WOMEN AFTER ELECTRONCONVULSIVE TREATMENTHARNRYD C; BJERKENSTEDT L; GRIMM VE et al.1979; PSYCHOPHARMACOLOGY; DEU; DA. 1979; VOL. 64; NO 2; PP. 131-134; BIBL. 27 REF.Article

A DOUBLE-BIND COMPARISON OF MELPERONE AND THIOTHIXENE IN PSYCHOTIC WOMEN USING A NEW RATING SCALE, THE CPRSBJERKENSTEDT L; HARNRYD C; GRIMM V et al.1978; ARCH. PSYCHIATR. NERVENKRANKH.; DEU; DA. 1978; VOL. 226; NO 3; PP. 157-172; BIBL. 3 P.Article

FAILURE TO DETECT IMMUNOLOGIC STIGMATA IN SCHIZOPHRENIAEHRNST A; WIESEL FA; BJERKENSTEDT L et al.1982; NEUROPSYCHOBIOLOGY; ISSN 0302-282X; CHE; DA. 1982; VOL. 8; NO 4; PP. 169-171; BIBL. 9 REF.Article

CLINICAL ASSESSMENT OF DOPAMINE RECEPTOR BLOCKADESEDWALL G; BJERKENSTEDT L; LINDSTROM L et al.1978; LIFE SCI.; GBR; DA. 1978; VOL. 23; NO 5; PP. 425-430; BIBL. 11 REF.Conference Paper

Tyrosine transport as an indicator of cell membrane dysfunction in schizophreniaWIESEL, F.-A; BJERKENSTEDT, L.Prostaglandins, leukotrienes and essential fatty acids. 1996, Vol 55, Num 1-2, pp 55-58, issn 0952-3278Conference Paper

MONOAMINE METABOLITE LEVELS IN CEREBROSPINAL FLUID OF PSYCHOTIC WOMEN TREATED WITH MELPERONE OR THIOTHIXENE.BJERKENSTEDT L; GULLBERG B; HARNRYD C et al.1977; ARCH. PSYCHIATR. NERVENKRANKH.; DTSCH.; DA. 1977; VOL. 224; NO 2; PP. 107-118; BIBL. 2 P.Article

The effects of citalopram (Lu 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patientsBEVING, H; BJERKENSTEDT, L; MALMGREN, R et al.Journal of neural transmission. 1985, Vol 61, Num 1-2, pp 95-104, issn 0300-9564Article

Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopramBJERKENSTEDT, L; FLYCKT, L; OVERØ, K. F et al.European journal of clinical pharmacology. 1985, Vol 28, Num 5, pp 553-557, issn 0031-6970Article

Decreased tyrosine transport inf fibroblasts from sxhieophrenic patientsHAGENFELDT, L; VENIZELOS, N; BJERKENSTEDT, L et al.Life sciences (1973). 1987, Vol 41, Num 25, pp 2749-2757, issn 0024-3205Article

Evidence of disturbed CSF circulation and brain atrophy in cases of schizophrenic psychosisOXENSTIERNA, G; BERGSTRAND, G; BJERKENSTEDT, L et al.British journal of psychiatry (Print). 1984, Vol 144, pp 654-661, issn 0007-1250, INDEXArticle

Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controlsFLYCKT, L; SYDOW, O; BJERKENSTEDT, L et al.Psychiatry research. 1999, Vol 86, Num 2, pp 113-129, issn 0165-1781Article

Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjectsHAGENFELDT, L; BJERKENSTEDT, L; EDMAN, G et al.Journal of neurochemistry. 1984, Vol 42, Num 3, pp 833-837, issn 0022-3042Article

Muscle biopsy findings, conduction velocity and refractory period of single motor nerve fibres in schizophreniaBORG, J; EDSTROM, L; BJERKENSTEDT, L et al.Journal of neurology, neurosurgery and psychiatry. 1987, Vol 50, Num 12, pp 1655-1664, issn 0022-3050Article

Scale construction of the swedish CPRS versionVON LUCKNER, N; WOGGON, B; ÅSBERG, M et al.Neuropsychobiology. 1985, Vol 13, Num 4, pp 180-186, issn 0302-282XArticle

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controlsBJERKENSTEDT, L; EDMAN, G; HAGENFELDT, L et al.British journal of psychiatry (Print). 1985, Vol 147, pp 276-282, issn 0007-1250, INDEXArticle

Tyrosine transport in schizophreniaWIESEL, F. A; VENIZELOS, N; BJERKENSTEDT, L et al.Schizophrenia research. 1994, Vol 13, Num 3, pp 255-258, issn 0920-9964Conference Paper

Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor: a dose-response study in depressed patientsBJERKENSTEDT, L; EDMAN, G; FLYCKT, L et al.Psychopharmacologia. 1985, Vol 87, Num 3, pp 253-259, issn 0033-3158Article

Tyrosine transport is regulated differently in patients with schizophreniaWIESEL, F.-A; ANDERSSON, J. L. R; WESTERBERG, G et al.Schizophrenia research. 1999, Vol 40, Num 1, pp 37-42, issn 0920-9964Article

Aberrant amino acid transport in fibroblasts from patients with bipolar disorderPERSSON, M. L; JOHANSSON, J; VUMMA, R et al.Neuroscience letters. 2009, Vol 457, Num 1, pp 49-52, issn 0304-3940, 4 p.Article

Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophreniaFLYCKT, L; BORG, J; BORG, K et al.Biological psychiatry (1969). 2000, Vol 47, Num 11, pp 991-999, issn 0006-3223Article

The transport of tyrosine into the human brain as determined with L-[1-¹¹C]tyrosine and PETWIESEL, F.-A; BLOMQVIST, G; HALLDIN, C et al.JNM : (1990). 1991, Vol 32, Num 11, pp 2043-2049Article

A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosisBAASTRUP, P. C; ALHFORS, U. G; LINDHOLM, H et al.Acta psychiatrica Scandinavica. 1993, Vol 87, Num 1, pp 48-58, issn 0001-690XArticle